A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Early Breast Cancer
Interventions: DRUG: Cyclophosphamide|DRUG: Doxorubicin|DRUG: Docetaxel|DRUG: Paclitaxel|DRUG: Pertuzumab IV|DRUG: FDC of Pertuzumab and Trastuzumab SC|DRUG: Trastuzumab IV|DRUG: Trastuzumab SC|PROCEDURE: Surgery|RADIATION: Post-operative Radiotherapy|DRUG: Hormone Therapy
Sponsor: Hoffmann-La Roche